Object Endovascular treatment of cerebral vasospasm consists primarily of transluminal balloon angioplasty (TBA) and intra-arterial (IA) vasodilator administration, the former restricted to use within the distal internal carotid and proximal intracerebral arteries. Our objective was to characterize clinical and angiographic features of those patients undergoing TBA and IA vasodilator treatments, particularly as it related to the aneurysm treatment modality.
Methods Retrospective analysis of consecutive patients admitted for aneurysmal SAH undergoing IA treatment for cerebral vasospasm (n=73) examining clinical and angiographic variables. Continuous and ordinal means were examined with Mann–Whitney and Student t tests while nominal values were examined with χ2/Fisher's exact tests. Multivariate logistic and linear regression included admission Glasgow coma scale, age, number of aneurysms and number of vasospastic vessels.
Results Those patients receiving IA vasodilator in isolation (n=16) were older (45.9 vs 59.1 years, p=0.001) and more frequently had vasospasm involving the anterior cerebral artery alone (0.0% vs 31.3%, p <0.001). The use of an IA vasodilator alone or in combination with TBA more frequently occurred in the coiled population (32.3% vs 50.1%, p=0.021).
Conclusion TBA and IA vasodilators are safe and effective means to treat cerebral vasospasm. Their use for proximal and distal vasospasm, respectively, and in tandem for diffuse disease, suggests regional differences in cerebral vasospasm between surgical clipping and endovascular coiling populations with coiled patients more often having distal vasospasm. Craniotomy and/or hemorrhagic evacuation performed during open surgery may contribute to this difference.
- subarachnoid hemorrhage
- interventional radiology
Statistics from Altmetric.com
Portions of this work were presented in abstract form at the 5th annual meeting of the Society of Neurointerventional Surgery, Lake Tahoe, California, July 29, 2008.
Competing interests None.
Ethics approval This study was conducted with the approval of the Cerebrovascular outcomes registry. University of Washington Institutional Review Board #31833 FWA 00006878.
Provenance and peer review Not commissioned; not externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.